Clariane SE/€CLARI
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Clariane SE
Clariane SE is a French company specializing in care services for vulnerable individuals, operating across six European countries: France, Germany, Belgium, Italy, the Netherlands, and Spain. Its core activities are divided into three segments: long-term care, specialty care, and community care. Long-term care includes nursing homes and assisted living facilities; specialty care encompasses post-acute and rehabilitation services, mental health clinics, and home hospitalization; and community care offers shared living solutions and home care services. Founded in 2001 and formerly known as Korian, the company rebranded to Clariane SE in June 2023 and adopted the status of a purpose-driven company, emphasizing its commitment to addressing societal challenges related to aging and vulnerability. Headquartered in Paris, Clariane operates over 1,200 facilities, employing approximately 63,000 staff members. Its strategic positioning focuses on providing personalized care solutions integrated within local communities, leveraging a diversified service portfolio to meet the complex needs of an aging population. (,,)
- Ticker
- €CLARI
- Sector
- Health
- Primary listing
- PAR
- Employees
- 70,685
- Headquarters
- Paris, France
- Website
- www.clariane.com
Clariane SE Metrics
BasicAdvanced
€1.1B
95.41
€0.03
0.82
-
Price and volume
Market cap
€1.1B
Beta
0.82
52-week high
€4.38
52-week low
€2.99
Average daily volume
416K
Financial strength
Current ratio
0.841
Quick ratio
0.779
Long term debt to equity
1.773
Total debt to equity
2.131
Dividend payout ratio (TTM)
696.84%
Interest coverage (TTM)
1.60%
Profitability
EBITDA (TTM)
640.305
Gross margin (TTM)
31.28%
Net profit margin (TTM)
0.23%
Operating margin (TTM)
9.38%
Effective tax rate (TTM)
22.35%
Revenue per employee (TTM)
€80,000
Management effectiveness
Return on assets (TTM)
2.18%
Return on equity (TTM)
0.67%
Valuation
Price to earnings (TTM)
95.41
Price to revenue (TTM)
0.213
Price to book
0.32
Price to tangible book (TTM)
-0.69
Price to free cash flow (TTM)
1.344
Free cash flow yield (TTM)
74.39%
Free cash flow per share (TTM)
2.374
Growth
Revenue change (TTM)
0.84%
Earnings per share change (TTM)
-119.30%
3-year revenue growth (CAGR)
4.18%
10-year revenue growth (CAGR)
6.78%
3-year earnings per share growth (CAGR)
23.06%
10-year earnings per share growth (CAGR)
-24.00%
What the Analysts think about Clariane SE
Analyst ratings (Buy, Hold, Sell) for Clariane SE stock.
Analyst projections of the future price of Clariane SE stock.
Bulls say / Bears say
First-half organic revenue rose 4.6%, with nursing-home occupancy climbing to 91.7% from 90.5% a year earlier. Higher occupancy and pricing support further growth from the existing estate. (Clariane)
Operating momentum is improving: first-half EBITDA rose 14.9% on a comparable basis and its margin widened to 10.4% from 9.5%. OpCo EBITDA grew 25.1%, suggesting operational changes are beginning to lift profitability. (Clariane)
Clariane has refinanced key borrowing and extended funding access, including €500 million of senior notes due 2032 and a new €700 million revolving facility due 2031. This reduces near-term refinancing pressure and gives the group more liquidity flexibility. (GlobeNewswire, GlobeNewswire)
Leverage remains high: it stood at 4.9 times at June-end and would be 5.4 times after the planned hybrid redemption. Clariane’s stated target is to bring it below 5.5 times by year-end 2026, leaving limited headroom if performance weakens. (Clariane)
Cash generation remains thin relative to the debt load: first-half operating free cash flow was just €20 million, while the group reported a €48 million net loss. Financial expenses and taxes paid rose to €124 million from €110 million a year earlier. (Clariane)
Care-quality and legal concerns pose a reputational and potential liability risk: a Clariane-run French care home has been sent to trial over a resident’s fatal scalding, and families have since filed complaints alleging neglect at another home. Such scrutiny could harm trust and bring costs or tighter oversight. (Mediapart, Le Parisien)
Data summarised monthly by Lightyear AI. Last updated on 18 Oct 2026.
Clariane SE Financial Performance
Revenues and expenses
Clariane SE Earnings Performance
Company profitability
Upcoming events
No upcoming events
Funds containing Clariane SE
AllUSDEURGBP
Fund name | Fund size | €CLARI weighting |
|---|---|---|
iShares Ageing Population$AGED | $953M | 0.05% |
iShares Ageing Population€AGED | $903M | 0.05% |
iShares Ageing Population£AGES | $953M | 0.05% |
Xtrackers MSCI Europe Small Cap£XXSC | $3.6B | 0.03% |
Xtrackers MSCI Europe Small Cap€DX2J | $3.6B | 0.03% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.